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ABSTRACT
Objectives Assess the effectiveness of 5* GRIP- 
rated slip- resistant footwear in preventing slips in 
the workplace compared to usual footwear (control 
group).
Methods A multicentre, randomised controlled 
trial; 4553 National Health Service (NHS) staff were 
randomised 1:1 to the intervention group (provided 
with 5* GRIP- rated slip- resistant footwear) or the 
control group. The primary outcome of incidence rate of 
self- reported slips in the workplace over 14 weeks was 
analysed using a mixed- effects negative binomial model. 
Secondary outcome measures included incidence rate 
of falls from a slip, falls not from a slip, proportion of 
participants reporting a slip, fall or fracture and time to 
first slip and fall.
Results 6743 slips were reported: 2633 in the 
intervention group (mean 1.16 per participant, range 
0 to 36) and 4110 in the control group (mean 1.80 
per participant, range 0 to 83). There was a statistically 
significant reduction in slip rate in the intervention 
group relative to the control group (incidence rate ratio 
(IRR) 0.63, 95% CI 0.57 to 0.70, p<0.001). Statistically 
significant differences, in favour of the intervention 
group, were observed in falls from a slip (IRR 0.51, 
95% CI 0.28 to 0.92, p=0.03), the proportion of 
participants who reported a slip (OR 0.58, 95% CI 0.50 
to 0.66, p<0.001) or fall (OR 0.73, 95% CI 0.54 to 0.99, 
p=0.04) and time to first slip (HR 0.73, 95% CI 0.67 to 
0.80, p<0.001).
Conclusions The offer and provision of 5* GRIP- rated 
footwear reduced slips in NHS staff in the workplace.
Trial registration number ISRCTN33051393.
INTRODUCTION
Slips, trips and falls on the same level are a major 
cause of injury in the workplace. In Great Britain, 
they are a common cause of non- fatal injury to 
employees, accounting for around 30% of those 
reported to the Health and Safety Executive (HSE).1 
An estimated 100 000 non- fatal workplace injuries 
occur each year due to a slip, trip or fall on the 
level,2 resulting in 867 000 annual lost working days 
(full day equivalent).3 The issue is compounded by 
an ageing workforce.4 Those at older ages are more 
likely to fall and sustain more serious injuries when 
they do fall.5 6
Several factors can contribute to slips in the 
workplace including: the type of floor surface, 
whether it is contaminated, how it is cleaned and 
the type of footwear worn. In situations where it is 
impossible to prevent the floor becoming slippery, 
slip- resistant footwear should be considered to mini-
mise the risk of slips. There is evidence to suggest 
that slip- resistant footwear is effective. A longitu-
dinal study evaluating a slip, trip and fall preven-
tion programme in US hospital workers,7 which 
included slip- resistant shoes among other strategies, 
reported a 58% reduction in workers’ compensa-
tion claims. A cluster randomised controlled trial 
(RCT) that recruited food service workers from 226 
school districts in the USA, showed the probability 
of experiencing a slip injury was reduced by 67% 
in those allocated to receive appropriately specified 
slip- resistant shoes.8
Selecting appropriate slip- resistant footwear 
can be challenging as there is a lack of robust 
testing and reliable information on which to base 
a decision. The HSE in Great Britain developed the 
Key messages
What is already known about this subject?
 ► There is some low- level evidence from previous 
studies to suggest that slip- resistant footwear 
can prevent slips, although it can be challenging 
to identify appropriate slip- resistant footwear 
due to the lack of robust testing and reliable 
information on which to base a decision.
What are the new findings?
 ► The Health and Safety Executive in Great Britain 
developed the GRIP- rating schemefor the 
assessment and classification of footwear slip 
resistance, and when 5* GRIP- rated footwear 
were tested in this trial, they were found to 
reduce the rate of slips by 37% and the rate of 
falls resulting from a slip by 49% among NHS 
employees.
How might this impact on policy or clinical 
practice in the foreseeable future?
 ► Slip- resistant footwear should be considered 
in areas where it is not possible to minimise or 
adequately control a potential slip risk.
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GRIP- rating scheme to measure and grade the slip resistance of 
footwear.9 This scheme goes beyond the minimum level required 
under the British and European standards;10 it evaluates foot-
wear in simulated, ‘lifelike’ conditions, which provides a more 
accurate indication of the slip- resistant properties of the foot-
wear. The Stopping Slips among Healthcare Workers (SSHeW) 
trial evaluated the effectiveness of 5* GRIP- rated slip- resistant 
footwear (the highest possible rating) to reduce slips in National 
Health Service (NHS) employees working in general, clinical 
or catering areas. This article reports the effectiveness results; 




Between March 2017 and January 2019, we enrolled partic-
ipants in this two- arm, multicentre RCT at seven NHS trusts 
in England. Details of the trial design and implementation are 
provided in the published protocol.11
Participants
NHS employees were provided with trial information, which 
included a consent form, and a baseline questionnaire to collect 
eligibility and demographic data. Participants were eligible for 
the trial if they: worked in a clinical, general or catering area; 
were aged 18 years and over; worked at least 22.5 hours a 
week; had a mobile phone; and were willing to receive/send 
text messages for data collection. We excluded them if they 
were: required to wear protective footwear by their employer; 
predominantly office or theatre- based; agency staff or staff with 
less than 6 months remaining on their employment contract. All 
participants provided written informed consent.
Changes to study design
To aid recruitment, after input from the TSC/DMEC 
(TrialSteering and Data Monitoring and Ethics committee) and 
with the funder’s agreement, the eligibility criterion regarding 
working hours was revised in April 2018. Initially participants 
were required to work, on average, at least 80% working time 
equivalent (WTE), 30 hours per week. This was reduced to 60% 
WTE (22.5 hours per week). Participating sites had saturated the 
eligible workforce and found that the number of hours worked 
was the predominant factor limiting others from taking part. 
The required number of working hours was dropped to no lower 
than 22.5 so participants were working a sufficient amount of 
time to (a) ensure a sufficient work- related slip rate and (b) 
retain the ability to detect a reduction in this slip rate. It was 
felt that if the working hours had been reduced further, then it 
would not have been possible to do this.
Randomisation and masking
Participants were inducted into the trial with a welcome text 
message followed by a pre- randomisation ‘run- in’ period of data 
collection in the form of weekly text messages, for up to 6 weeks, 
requesting data on slips at work in the previous week. The 
purpose of the ‘run- in’ period was twofold: to provide a baseline 
slip rate; and to assess for engagement with the text message 
data collection process. By only randomising participants who 
provided slip data for at least 2 weeks, we hoped to maximise 
response to the post- randomisation outcome texts. Participants 
were randomised 1:1 to either be offered and provided with a pair 
of 5* GRIP- rated slip- resistant shoes or asked to wear their usual 
work shoes. Randomisation was through the University of York, 
York Trials Unit (YTU) secure, remote, web- based randomisation 
service. The allocation sequence was generated by an indepen-
dent data systems manager at YTU, who was not involved in the 
recruitment of participants. Sites informed YTU when they had 
capacity to order and deliver footwear. Block randomisation, 
stratified by trust, was used. The block size varied and was equal 
to the number of participants to be randomised in each batch, 
which was determined by site capacity (range 2 to 335, median 
14). Participants and members of the study team including the 
statistician, health economist and those involved in the admin-
istration of the study were not masked to treatment allocation.
Intervention
Intervention arm participants were offered and provided with a 
pair of 5* GRIP- rated slip- resistant shoes12 to wear during the 
14- week trial period. In the GRIP- rating scheme, shoe manu-
facturers pay to have their footwear tested. Depending on their 
performance, the footwear is assigned a rating from one to five 
stars, with five indicating the best performing. The footwear 
for this trial was provided by a single manufacturer (Shoes For 
Crews Ltd), who had no input into the design, conduct or anal-
ysis of the study. This company was selected as it was able to 
supply large numbers of 5* GRIP- rated shoes in various styles 
over a wide geographical area. The cost of the footwear was 
covered by the NHS trust or trust’s charities. The shoes had a 
rubber sole with an intricate tread pattern (figure 1). The tread 
provided a large surface contact area while also being able to 
disperse surface contamination. However, when walking on 
clean and dry surfaces, the footwear was expected to behave like 
any other footwear.
Control
Control arm participants continued to wear their usual work 
shoes for the 14- week trial period. Trusts’ footwear policy stated 
footwear should be sensible, low- heeled and not open- toed. 
Only four of the trusts stipulated that non- slip footwear should 
be worn, but none stated how this should be assessed. After 
the trial, control participants were offered a free pair of the 5* 
GRIP- rated slip- resistant shoes.
Follow-up
Participants were sent weekly text messages for 14 weeks to 
collect slip outcome data and a 14- week post- randomisation 
follow- up postal questionnaire. On reporting their first slip, 
participants were sent a slip data collection questionnaire to ask 
whether they were wearing the trial shoes when they slipped, 
location of slip and any resulting injuries. If an injury was 
reported this was followed up with monthly data collection 
until the injury resolved, the participant no longer wished to 
be contacted or the trial ended. Participants in the intervention 
Figure 1 Example of sole of intervention footwear.
copyright.











ed: first published as 10.1136/oem




3Cockayne S, et al. Occup Environ Med 2021;0:1–7. doi:10.1136/oemed-2020-106914
Workplace
group were also sent text messages at 6, 10 and 14 weeks post- 
randomisation to collect data on how often they wore the trial 
shoes.
Outcomes
The primary outcome was the incidence rate of self- reported 
slips, not necessarily resulting in a fall or injury, in the workplace 
over the 14 weeks from randomisation, as reported via weekly 
text messages (or the 14- week questionnaire where no text 
messages were received). A slip was defined as ‘a loss of traction 
of your foot on the floor surface, which may or may not result 
in a fall’. A fall was defined as ‘an unexpected event in which 
you come to rest on the ground, floor or lower level’. Secondary 
outcomes included the incidence rate of falls both resulting from 
a slip and not resulting from a slip in the workplace over 14 
weeks, the proportion of participants who reported a slip, fall 
or fracture over 14 weeks and time to first fall and first slip. 
Other data collected included: issues with wearing footwear and 
adverse events, which were collected via the 14- week follow- up, 
slip data collection and injury questionnaires or responses to text 
messages; and compliance with wearing the trial shoes, which 
was collected via the 14- week questionnaire and text messages 
sent at 6, 10 and 14 weeks.
Sample size
There were limited published data on which to base a sample 
size calculation for this trial. A prospective cohort study13 found 
that 49 of 422 (11.6%) workers in a restaurant setting in the 
USA reported at least one ‘major’ (ie, resulting in a fall and/or 
injury) slip over a 12- week follow- up period. It was therefore 
expected that the proportion of workers that experienced any 
type of slip would be higher than this, though the exact figure 
was not reported. For this sample size calculation, a conservative 
estimate of a proportion of 10% of the control group that would 
experience at least one slip over a 14- week follow- up period 
was assumed. Randomising 4400 participants 1:1 (ie, 2200 per 
group) would provide 90% power to show a 30% relative reduc-
tion in the proportion of participants who report at least one slip 
over 14- weeks (3 percentage point absolute reduction from 10% 
to 7%) allowing for 20% attrition. This sample size would also 
give 80% power to see an absolute reduction in the risk of falls 
from 5.5% to 3.5% allowing for 20% attrition. Although the 
sample size calculation was based on detecting a difference in 
proportions, the primary outcome was the incidence rate of slips 
over the 14 weeks and so negative binomial regression was used 
to compare this outcome between the two groups. Since this 
analysis used more information than a simple binary outcome, it 
was considered to be adequately powered.
Statistical analysis
Statistical analyses were conducted in Stata V.15 (StataCorp, 4905 
Lakeway Drive, College Station, Texas 77845, USA), following 
the principles of intention- to- treat analysing participants in the 
groups to which they were originally assigned regardless of 
compliance (or not) with allocation, using two- sided significance 
of 0.05. The follow- up period for all participants commenced on 
the date of randomisation and lasted a maximum of 14 weeks; 
therefore, for intervention participants, this often included some 
weeks at the start when they had not yet received their shoes. For 
the primary analysis of the incidence rate of slips, a mixed- effects 
Figure 2 Flow of participants through trial. an=1930, 85% received trial shoes within 14- week trial follow- up. NHS, National Health Service; SMSs, short 
messaging services; WTE, working time equivalent.
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negative binomial model was used adjusting for gender, job 
role and baseline weekly slip rate as fixed effects and site as a 
random effect. The model took account of the number of weeks 
for which slip data were provided and the total hours worked 
during those weeks. The person- working- hours were calculated 
by multiplying the number of weeks for which the participant 
provided slip data by the average number of hours they told us 
they tended to work in a week. We assumed participants were 
working in the weeks for which they provided data. The primary 
analysis was undertaken by CF and checked by GF. Complier 
average causal effect (CACE) analyses were undertaken for the 
primary outcome to account for the number of weeks partic-
ipants had their shoes and the amount of time they reported 
wearing them.
The incidence rate of falls (both resulting and not resulting 
from a slip) over 14 weeks was analysed in the same way as 
the primary outcome. Mixed- effects logistic regression adjusted 
as for the primary analysis was used to compare, between the 
two groups, the proportions of participants who: (1) slipped 
at least once over 14 weeks; and (2) fell at least once over 14 
weeks. The time from randomisation to first slip was analysed by 
Cox proportional hazards regression. Proportion of participants 
reporting a fracture and time to first fall were summarised 
descriptively but not formally analysed due to the small number 
of events.
Public involvement
The SSHeW study was informed by the involvement of NHS 
staff (aged 20 to 71 years) from diverse roles including nurses, 
catering, housekeeping and doctors. They provided feedback 
about: rationale for the trial; shoe styles; use of text messages to 
collect data; use of a slip diary; the length of the follow- up; foot-
wear buying habits; and testing slip- resistance of staff ’s usual 
shoes. An NHS employee was a member of the TSC/DMEC.
RESULTS
Participants were recruited between March 2017 and November 
2018 and randomised between June 2017 and January 2019. 
Trial invitation packs were sent to 8524 NHS staff, with 5309 
(62.3%) returning a consent form and baseline questionnaire 
indicating they wished to take part. A total of 4808 were eligible 
and were sent up to six pre- randomisation, weekly texts. Of 
these, 4554 participants provided valid slip data to at least two 









  Mean (SD) 42.7 (11.5) 42.7 (11.3) 42.7 (11.4)
  Median (min, max) 44.0 (19.0 to 74.0) 44.0 (18.0 to 71.0) 44.0 (18.0 to 74.0)
Gender (Female), n (%) 1948 (85.6) 1921 (84.3) 3869 (85.0)
Average number of hours worked per week
  Mean (SD) 35.8 (4.3) 35.8 (4.5) 35.8 (4.4)
  Median (min, max) 37.5 (22.5 to 63.0) 37.5 (15.0 to 62.0) 37.5 (15.0 to 63.0)
Job type, n (%)
  Qualified nurse/midwife 952 (41.8) 985 (43.2) 1937 (42.5)
  Support worker 286 (12.6) 276 (12.1) 562 (12.3)
  Healthcare assistant 272 (12.0) 246 (10.8) 518 (11.4)
  Other qualified staff/healthcare professional 150 (6.6) 163 (7.2) 313 (6.9)
  Domestic services 115 (5.1) 110 (4.8) 225 (4.9)
  Administrator/receptionist/secretarial 78 (3.4) 100 (4.4) 178 (3.9)
  Occupational therapist 65 (2.9) 65 (2.9) 130 (2.9)
  Imaging 64 (2.8) 53 (2.3) 117 (2.6)
  Physiotherapist 68 (3.0) 36 (1.6) 104 (2.3)
  Pharmacist/pharmacy technician 50 (2.2) 53 (2.3) 103 (2.3)
  Ward clerk 44 (1.9) 49 (2.2) 93 (2.0)
  Doctor/consultant 38 (1.7) 42 (1.8) 80 (1.8)
  Catering 29 (1.3) 38 (1.7) 67 (1.5)
  Other 51 (2.2) 45 (2.0) 96 (2.1)
Areas worked in, n (%)*
  Ward 1261 (55.4) 1199 (52.6) 2460 (54.0)
  Clinical room/area 722 (31.7) 755 (33.1) 1477 (32.4)
  Community 260 (11.4) 268 (11.8) 528 (11.6)
  Indoor hospital grounds/corridors 160 (7.0) 183 (8.0) 343 (7.5)
  Office 91 (4.0) 113 (5.0) 204 (4.5)
  Food preparation/serving area 77 (3.4) 87 (3.8) 164 (3.6)
  Other 80 (3.5) 118 (5.2) 198 (4.3)
Had slip at work in the 12 months prior to enrolling in the study, n (%) 850 (37.4) 885 (38.8) 1735 (38.1)
If yes, how many? Median (min, max) 2 (1 to 400) 2 (1 to 300) 2 (1 to 400)
Suffered injury from any of these slips, n (%) 96 (11.3) 89 (10.1) 185 (10.7)
*not mutually exclusive.
%, percentage; max, maximum; min, minimum; n, number; SD, standard deviation.
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of the texts and were randomised into the trial (intervention 
group, n=2276; control group, n=2278). One participant was 
immediately withdrawn as they were found to be ineligible. 
Figure 2 shows the participant flow during the trial and reports 
the reasons why participants were ineligible for the study.
Participant characteristics
Baseline characteristics were well balanced across groups (table 1, 
and see online supplemental 1). Most participants were women 
(n=3869, 85.0%) and the average age was 42.7 years (range 18 
to 74). Participants worked a median of 37.5 hours a week, and 
the majority were qualified nurses/midwives (n=1937, 42.5%). 
Just over one- third reported at baseline that they had experi-
enced a slip at work in the previous 12 months (median of two 
slips), of which 11% had suffered an injury as a result of one of 
these slips.
Primary outcome
At least 1 weeks’ worth of post- randomisation SMS (shortmes-
saging service) slip data were available from 4494 randomised 
participants (98.7%; intervention group, n=2254, 99.1%; 
control, n=2240, 98.3%) (see online supplemental 2). A further 
11 (intervention group, n=4; control group, n=7) did not 
respond to any text messages, but provided data for number 
of slips experienced on their 14- week questionnaire, so were 
included in the primary model. The primary model also included 
participants who did not provide any post- randomisation slip 
data, by considering that they reported zero slips over a minimal 
exposure time of 0.1 hours. In total, the intervention group 
reported 2633 slips over 28 002 person- weeks, which equates 
to approximately 1 001 959 person- working- hours (mean per 
randomised participant 1.16, SD 2.9, median 0, range 0 to 36), 
and the control group reported 4110 slips over 28 595 person- 
weeks, or 1 025 180 person- working- hours (mean 1.80, SD 4.6, 
median 0, range 0 to 83). In total, 1824/4505 (40.5%) partic-
ipants reported at least one slip. Information about a partici-
pant’s first slip was received for 1159 (63.5%) (intervention 
group, 61.9%; control group, 65.0%) (see online supplemental 
3). Nearly all occurred on the ward (96.9%) and over three- 
quarters on a smooth surface. Only 3.0% of slips lead to a 
fall and most did not result in an injury (86.4%). There were 
no reported fractures from the first reported slip, though one 
control participant later reported a broken ankle due to a subse-
quent slip.
The incidence rates of slips per person- working- week were 
approximately 0.10 (95% CI 0.09 to 0.11) in the intervention 
group and 0.15 (95% CI 0.14 to 0.17) in the control group. 
There was a 37% reduction in the slip rate in the intervention 
group relative to the control group (incidencerate ratio (IRR) 
0.63, 95% CI 0.57 to 0.70, p<0.001) (table 2). Of the 2275 inter-
vention participants, 1523 (66.9%) received a pair of trial shoes 
within 7 weeks of randomisation, and 1930 (84.8%) within 14 
weeks (median 27 days post- randomisation). Some participants 
either did not receive or were delayed in receiving their footwear 
due to issues with ordering, distributing or collecting footwear. 
Of the 28 002 person- weeks of slip data provided by inter-
vention participants, we estimate two- thirds (18 696, 66.8%) 
of these were after they had received their shoes. Compliance 
data indicated that, once they had received their trial footwear, 
50% of intervention participants wore the shoes all of the time 
while at work. A similar treatment estimate was observed when 
CACE analysis explored the impact of receiving shoes within 
seven (IRR 0.65, 95% CI 0.58 to 0.73, p<0.001) and 14 weeks 
(IRR 0.65, 95% CI 0.59 to 0.73, p<0.001) (table 2). A compli-
ance ‘score’ was also computed, which incorporated when shoes 
were received and the amount of time they were worn, where 
a higher score indicated greater compliance. The intervention 
group scored, on average, 5.2/12 (SD 4.4); the control group 
all scored 0. The CACE analysis indicated that for every unit 
increase in compliance score, the rate of slipping was reduced by 
approximately 5% (IRR 0.95, 95% CI 0.94 to 0.97, p<0.001).
Secondary outcomes
Statistically significant findings, favouring the slip- resistant 
footwear, were seen in the following secondary outcomes: falls 
resulting from a slip in the workplace (IRR 0.51, 95% CI 0.28 
to 0.92, p=0.03), the proportion of participants who reported 
a slip (OR 0.58, 95% CI 0.50 to 0.66, p<0.001) or fall (OR 
0.73, 95% CI 0.54 to 0.99, p=0.04) and time to first slip (HR 
0.73, 95% CI 0.67 to 0.80, p<0.001) (table 2). There was no 
evidence of a difference in falls not resulting from a slip (IRR 
0.82, 95% CI 0.50 to 1.34, p=0.44). First falls were reported a 






Adjusted treatment effect estimate
(95% CI) P value
Primary analysis*
  Total number of slips 2633 4110   
  Mean (SD) 1.16 (2.9) 1.80 (4.6) IRR 0.63 (0.57 to 0.70) <0.001
CACE sensitivity analyses*   
  Receiving shoes within 7 weeks, n (%) 1523 (66.9) 0 (0.0) IRR 0.65 (0.58 to 0.73) <0.001
  Receiving shoes within 14 weeks, n (%) 1930 (84.8) 0 (0.0) IRR 0.65 (0.59 to 0.73) <0.001
  Continuous score (out of a possible 12), mean (SD) 5.2 (4.4) 0.0 (0.0) IRR 0.95 (0.94 to 0.97) <0.001
Secondary analyses*   
  1+slip, n (%) 804 (35.6) 1020 (45.4) OR 0.58 (0.50 to 0.66) <0.001
  1+fall†, n (%) 80 (3.5) 107 (4.7) OR 0.73 (0.54 to 0.99) 0.04
  Number of falls from a slip, mean (SD) 0.02 (0.22) 0.03 (0.23) IRR 0.51 (0.28 to 0.92) 0.03
  Number of falls not from a slip, mean (SD) 0.13 (0.9) 0.33 (2.1) IRR 0.82 (0.50 to 1.34) 0.44
  Time to first slip, 0.33 percentile days (95% CI) 46 (34 to 60) 27 (25 to 32) HR 0.73 (0.67 to 0.80) <0.001
*over 14 weeks.
†including those resulting from a slip and those not resulting from a slip.
%, percentage; CACE, complier average causal effect; CI, confidence interval; HR, hazard ratio; IRR, incidence rate ratio; n, number; OR, odds ratio; SD, standard deviation.
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median of 34 days after randomisation in the intervention group 




This randomised controlled trial showed that 5* GRIP- rated 
slip- resistant footwear reduced the rate of slips among NHS 
workers by 37%. Reductions were also seen in the proportion of 
participants who had a slip or fall.
Comparison to other studies
As far as we are aware there is only one previous RCT eval-
uating slip- resistant footwear.8 This differed in its design, as 
it was cluster randomised, and population as it involved food 
service workers in US schools (only 1.5% of SSHeW partic-
ipants were food service workers). The study also differed in 
its primary focus, which was to prevent workers’ compensation 
injury claims; therefore, it assessed slipping injuries rather than 
slips in general. A 67% reduction in the likelihood of reporting 
a slipping injury at follow- up relative to baseline was observed in 
the intervention arm, and this decrease was statistically signifi-
cantly higher than was seen in the control group. The SSHeW 
results are broadly consistent with non- trial evidence supporting 
the benefits of slip- resistant footwear including: a before and 
after study of Danish fishermen14 observed an 80% reduction 
in slips, trips and falls associated with wearing new boots with 
‘anti- slipping soles’; a 58% reduction in compensation claims 
when a slip, trip and fall prevention programme was introduced 
in a US hospital;8 and a 54% reduction in self- reported slipping 
in a cohort study involving fast food restaurant workers.13
Strengths and weaknesses of the study
The strengths of this study include its robust methodology, 
large sample size and high engagement. Almost every partici-
pant (98.7%) provided at least one valid response to the primary 
outcome text messages. The short (14- week) follow- up, use of 
a run- in period and weekly data collection may have contrib-
uted to the low post- randomisation attrition rate and minimised 
recall bias.
There are certain limitations to this study. Outcome data 
were participant self- reported and it wasn’t possible to blind 
participants to group allocation, which may have led to under- 
reporting or over- reporting of slips. Approximately 15% of 
intervention participants failed to receive their shoes within the 
14- week timeframe. These were considered non- compliant for 
the entire period, but were analysed as part of the intervention 
group under the principles of intention to treat, which may have 
diluted the observed treatment effect.
Meaning of the study
The preference would always be to try to minimise or adequately 
control a potential slip risk for individuals by eliminating, for 
example, floor surface contamination; however, this may not 
always be possible. In this situation, employers or staff may 
consider the use of slip- resistant footwear. The SSHeW study 
has shown clear evidence that the 5* GRIP- rated footwear used 
in this study can reduce slips, and falls resulting from slips, in the 
NHS workplace. There is, therefore, a role for appropriately- 
specified footwear in reducing slips in the workplace.
Unanswered questions and future directions
While the participants represented a diverse working group, our 
findings may not generalise to all workplaces. The trial should 
be replicated in other high- risk environments, such as manu-
facturing and food processing facilities or in settings that have 
different surfaces, such as in the construction industry.
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Time spent on feet at work, n (%)    
Most of the time 1843 (81.0) 1829 (80.3) 3672 (80.7) 
Some of the time 385 (16.9) 400 (17.6) 785 (17.2) 
A little of the time 11 (0.5) 18 (0.8) 29 (0.6) 
Missing 36 (1.6) 31 (1.4) 67 (1.5) 
Required to work in the community, n (%)    
Yes 552 (24.3) 554 (24.3) 1106 (24.3) 
No 1688 (74.2) 1689 (74.1) 3377 (74.2) 
Missing 35 (1.5) 35 (1.5) 70 (1.5) 
Have you had a fall at work in the past 12 
months?, n (%)    
Yes 188 (8.3) 192 (8.4) 380 (8.3) 
No 2039 (89.6) 2040 (89.6) 4079 (89.6) 
Don’t know 29 (1.3) 31 (1.4) 60 (1.3) 
Missing 19 (0.8) 15 (0.7) 34 (0.7) 
If yes, how many?    
Median (min, max) 1 (1, 52) 1 (1, 20) 1 (1, 52) 
Have you suffered injury from any of these 
falls?, n (%) 
69 (36.9) 74 (39.5) 144 (38.2) 
max, maximum; min, minimum; n, number; %, percentage 
 









N received / N sent (%) N received / N sent (%) N received / N sent (%) 
1 2109/2275 (92.7) 2112/2278 (92.7) 4221/4553 (92.7) 
2 2117/2272 (93.2) 2101/2278 (92.2) 4218/4550 (92.7) 
3 2079/2270 (91.6) 2094/2278 (91.9) 4173/4548 (91.8) 
4 2052/2269 (90.4) 2075/2276 (91.2) 4127/4545 (90.8) 
5 2063/2267 (91.0) 2068/2275 (90.9) 4131/4542 (91.0) 
6 2033/2265 (89.8) 2047/2272 (90.1) 4080/4537 (89.9) 
7 1967/2265 (86.8) 2055/2271 (90.5) 4022/4536 (88.7) 
8 1963/2261 (86.8) 2028/2271 (89.3) 3991/4532 (88.1) 
9 1962/2261 (86.8) 2034/2271 (89.6) 3996/4532 (88.2) 
10 1936/2259 (85.7) 2012/2271 (88.6) 3948/4530 (87.2) 
11 1948/2259 (86.2) 1996/2271 (87.9) 3944/4530 (87.1) 
12 1926/2256 (85.4) 1988/2271 (87.5) 3914/4527 (86.5) 
13 1921/2255 (85.2) 1996/2271 (87.9) 3917/4526 (86.5) 
14 1924/2253 (85.4) 1985/2269 (87.5) 3909/4522 (86.4) 
Response to at least one 
text message 2254/2275 (99.1%) 2240/2278 (98.3%) 4494/4553 (98.7%)  
Response to all 14 text 
messages   1289/2275 (56.7%) 1400/2278 (61.5%)  2689/4553 (59.1%) 
N, number, %, percentage 
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Hours worked in week of 
first slip 
   
Mean (SD) 35.7 (7.8) 35.6 (7.0) 35.6 (7.4) 
Median (min, max) 37.5 (3.5, 75.0) 37.5 (5.0, 75.0) 37.5 (3.5, 75.0) 
Type of slip, n (%)    
Slip without falling 
(however minor) 437 (87.9) 596 (90.0) 1033 (89.1) 
Slip and fall 12 (2.4) 23 (3.5) 35 (3.0) 
Missing 48 (9.7) 43 (6.5) 91 (7.9) 
Wearing trial shoes when 
slipped, n (%) 
   
Yes 82 (16.5) - - 
No 363 (73.0) - - 
Don’t know 3 (0.6) - - 
Missing 49 (9.9) - - 
Location of slip, n (%)    
On a ward or other 
clinical area in a hospital 479 (96.4) 644 (97.3) 1123 (96.9) 
In a non-clinical area in a 
hospital e.g. office, 
corridor 5 (1.0) 3 (0.5) 8 (0.7) 
In a catering area where 
food is prepared or 
served 1 (0.2) 0 (0.0) 1 (0.1) 
Outside 4 (0.8) 6 (0.9) 10 (0.9) 
Inside a patient's home 1 (0.2) 0 (0.0) 1 (0.1) 
Other 7 (1.4) 9 (1.4) 16 (1.4) 
Missing  0 (0.0) 0 (0.0) 0 (0.0) 
Slipped on…, n (%)    
Smooth surface 341 (68.6) 532 (80.4) 873 (75.3) 
Textured surface 92 (18.5) 77 (11.6) 169 (14.6) 
Missing 64 (12.9) 53 (8.0) 117 (10.1) 
Injuries suffered, n (%)a    
None 419 (84.3) 582 (87.9) 1001 (86.4) 
Superficial wound 12 (2.4) 17 (2.6) 29 (2.5) 
Broken bone  0 (0.0) 0 (0.0) 0 (0.0) 
Pulled muscle/sprained 
ligament 10 (2.0) 12 (1.8) 22 (1.9) 
Other 5 (1.0) 3 (0.5) 8 (0.7) 
Missing  52 (10.5) 49 (7.4) 101 (8.7) 
a not mutually exclusive 
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